Science
20 articles in the Science category
US Peptide Synthesis Reagents Market Analysis and Forecast
IndexBox has released a comprehensive market analysis for peptide synthesis reagents in the United States, covering size, trends, and forecasts. The report provides detailed insights into the industry's current state and future outlook. Key data points include market volume, value, and growth projections.
5 min readQnovia Obtains Global License for Antimicrobial Peptide Against Drug-Resistant Infections
Qnovia has secured a worldwide license for an antimicrobial peptide designed to combat drug-resistant infections. The agreement grants Qnovia exclusive global rights to develop and commercialize the peptide. This move aims to address the growing threat of antimicrobial resistance.
5 min readWeight-Loss Pill's Unexpected Effect Stuns Researchers
A new weight-loss pill produced an outcome that researchers did not anticipate. The finding, reported by Earth.com, challenges assumptions about how such medications work. Details of the study remain limited, but the unexpected result has drawn attention in the scientific community.
5 min read
AI Platform Aims to Accelerate Peptide Drug Discovery
A new artificial intelligence platform could significantly speed up the process of discovering peptide-based drugs. The technology, reported by EurekAlert, uses machine learning to predict and optimize peptide candidates, potentially reducing development timelines from years to months.
5 min readAI Platform from Penn Aims to Accelerate Peptide Drug Discovery
Researchers at the University of Pennsylvania have developed an artificial intelligence platform designed to speed up the discovery of peptide-based drugs. The platform uses machine learning to predict which peptide sequences are most likely to be effective, potentially reducing the time and cost of early-stage drug development.
6 min readEarly Antimicrobial Peptide Maturation Enables Host-Pathogen Coexistence
A study published in Bioengineer.org on July 15, 2026, reveals that the early maturation of antimicrobial peptide defenses in certain organisms allows them to coexist with pathogens. The research highlights how timing of immune system development can shape host-pathogen dynamics, potentially explaining why some species tolerate infections without disease.
5 min read
Penn Engineers Develop AI to Control Cellular Signals Using Peptides
Researchers at the University of Pennsylvania have created an artificial intelligence system that can control cellular signals by designing peptides. The AI, developed by engineers at Penn, represents a new approach to manipulating biological pathways with precision. The work was published in a peer-reviewed journal and could have implications for drug development and synthetic biology.
5 min read
LG AI Research and D&D Pharmatech Partner on Oral Peptide Drug Discovery
LG AI Research has announced a collaboration with D&D Pharmatech to accelerate the development of next-generation oral peptide drugs. The partnership aims to combine LG's artificial intelligence capabilities with D&D Pharmatech's expertise in peptide therapeutics to discover and develop orally bioavailable peptide drugs.
2 min readAscidian and Lilly Sign $1.9B RNA Editing Kidney Pact
Ascidian Therapeutics and Eli Lilly have signed a research collaboration potentially worth up to $1.9 billion. The agreement gives Eli Lilly the opportunity to discover and develop RNA exon editing therapeutics aimed at genetic kidney diseases. The deal focuses on advancing these treatments through joint research efforts.
2 min readOMI Peptide Formula Promises Thicker Hair in 90 Days
OMI has introduced a peptide formula that delivers thicker hair within 90 days. The product represents a breakthrough in peptide-based hair treatments. This development focuses on hair thickness improvement through targeted peptide application.
2 min read
Penn Study: Inconsistent GLP-1 Use May Cause Weight Gain
Researchers at the University of Pennsylvania discovered that intermittent use of GLP-1 drugs like semaglutide in mice led to weight gain and fat accumulation. The study from Penn's Leung Lab showed reduced drug effectiveness after cycling on and off the medication. About one in eight adults use these drugs for weight loss, but over half stop within two years and often restart.
2 min readFigure 2: Antimicrobial Peptide Axes Governing Amyloid Cross-Seeding
Figure 2 depicts antimicrobial peptide-centric design axes that govern cross-seeding with amyloids. This illustration centers on peptides in the design process for such interactions. The figure provides a focused view on these governing axes.
2 min readBachem (BCHMY) Cash From Operations TTM via Zacks Research
Zacks Investment Research covers cash from operations for the trailing twelve months for Bachem Holding AG - Unsponsored ADR (BCHMY). The data appears in their latest report. This financial detail highlights operational cash flow for the ADR ticker BCHMY.
2 min readEli Lilly Commits Up to $300M for CrossBridge Bio Buy
Eli Lilly has pledged up to US$300 million to purchase CrossBridge Bio. The target company stands as one of the most advanced in the dual-payload antibody-drug conjugate field. This deal centers on emerging ADC technology.
1 min read
Peptide-Guided Method Activates PAK1 Kinase
PAK1, a serine/threonine kinase involved in cardiac homeostasis, remains inactive due to an autoinhibitory link between its regulatory and kinase domains. Small GTPases Cdc42 or Rac1 disrupt this to activate it, creating a target for allosteric control. A bioactive PAK1-activating peptide (PAP) from the autoinhibitory area helps map this interface, as detailed in recent research.
2 min read
Peptide Profiling Decodes TCR Specificity for Autoantigen Find
Researchers developed a system combining high-throughput yeast display and fine-tuned protein language models to create deep peptide recognition profiles for TCRs. This approach details binding against millions of peptides and outperforms models like AlphaFold3 in predicting T cell activation. The method identified novel autoantigens for ankylosing spondylitis and acute anterior uveitis using HLA-B*27:05-restricted TCRs.
3 min readBreakthroughs in Faster, Cleaner Polypeptide Synthesis
Breakthroughs in polypeptide synthesis now provide faster and cleaner methods, as reported on May 13, 2026. These advances focus on improving the speed of the synthesis process. The cleaner techniques reduce impurities during production. This development appears in the science category and highlights key progress in polypeptide work.
2 min readPenn Scientists Build AI Tool for Faster Antibiotic Discovery
Scientists at the University of Pennsylvania have developed an AI tool designed to speed up antibiotic discovery. Penn researchers created this tool to make the process of finding new antibiotics quicker. Their work focuses directly on accelerating efforts in antibiotic development.
2 min readGenerative AI Optimizes Peptide Antibiotics in Nature
A study published in Nature on May 13, 2026, details a generative artificial intelligence approach for peptide antibiotic optimization. The paper focuses on this AI method applied to peptide antibiotics. Researchers present the approach in the journal Nature.
1 min read
Duke Professor Advances Research on GLP-1 Drugs
A Duke University associate professor of medicine, Jonathan Campbell, conducts research on GLP-1 drugs, which started for diabetes treatment and gained popularity for weight loss. His work examines GLP-1s and GIPs, incretin hormones, to clarify how these drugs function. Campbell highlights differences among current and upcoming GLP-1 drugs, stressing they are not one-size-fits-all, with much left to learn about safety and matching patients to treatments.
3 min readOther categories